217 related articles for article (PubMed ID: 15273422)
1. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
Vanecková I; Cahová M; Kramer HJ; Husková Z; Skaroupková P; Komers R; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2004; 27(4):203-10. PubMed ID: 15273422
[TBL] [Abstract][Full Text] [Related]
2. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
3. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
Husková Z; Kramer HJ; Vanourková Z; Cervenka L
J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
[TBL] [Abstract][Full Text] [Related]
4. Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats.
Kopkan L; Husková Z; Vanourková Z; Thumová M; Skaroupková P; Cervenka L; Majid DS
J Hypertens; 2007 Nov; 25(11):2257-65. PubMed ID: 17921820
[TBL] [Abstract][Full Text] [Related]
5. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
Vanecková I; Skaroupková P; Dvorák P; Certíková Chábová V; Tesar V; Bader M; Ganten D; Kramer HJ
Physiol Res; 2005; 54(1):17-24. PubMed ID: 15717837
[TBL] [Abstract][Full Text] [Related]
6. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.
Husková Z; Kramer H; Vanourková Z; Thumová M; Malý J; Opocenský M; Skaroupková P; Kolský A; Vernerová Z; Cervenka L
Kidney Blood Press Res; 2007; 30(1):45-55. PubMed ID: 17259738
[TBL] [Abstract][Full Text] [Related]
8. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
Kopkan L; Kramer HJ; Husková Z; Vanourková Z; Bäcker A; Bader M; Ganten D; Cervenka L
J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
[TBL] [Abstract][Full Text] [Related]
9. The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats.
Certíková Chábová V; Kramer HJ; Vanecková I; Thumová M; Skaroupková P; Tesar V; Falck JR; Imig JD; Cervenka L
Kidney Blood Press Res; 2007; 30(5):335-46. PubMed ID: 17785988
[TBL] [Abstract][Full Text] [Related]
10. Role of nNOS in regulation of renal function in hypertensive Ren-2 transgenic rats.
Cervenka L; Kramer HJ; Malý J; Vanecková I; Bäcker A; Bokemeyer D; Bader M; Ganten D; Mitchell KD
Physiol Res; 2002; 51(6):571-80. PubMed ID: 12511180
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats.
Chábová VC; Kramer HJ; Vanecková I; Vernerová Z; Eis V; Tesar V; Skaroupková P; Thumová M; Schejbalová S; Husková Z; Vanourková Z; Kolský A; Imig JD; Cervenka L
Vascul Pharmacol; 2007; 47(2-3):145-59. PubMed ID: 17604232
[TBL] [Abstract][Full Text] [Related]
12. General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system.
Castrop H; Klar J; Wagner C; Hocherl K; Kurtz A
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F518-24. PubMed ID: 12441308
[TBL] [Abstract][Full Text] [Related]
13. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
Opocenský M; Dvorák P; Malý J; Kramer HJ; Bäcker A; Kopkan L; Vernerová Z; Tesar V; Zima T; Bader M; Ganten D; Janda J; Vanecková I
Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
Patterson ME; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F205-11. PubMed ID: 17977909
[TBL] [Abstract][Full Text] [Related]
15. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats.
Jacinto SM; Mullins JJ; Mitchell KD
Am J Physiol; 1999 Feb; 276(2):F315-22. PubMed ID: 9950963
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Opay AL; Mouton CR; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2006 Sep; 291(3):F612-8. PubMed ID: 16622181
[TBL] [Abstract][Full Text] [Related]
17. Chronic cyclooxygenase-2 inhibition blunts low sodium-stimulated renin without changing renal haemodynamics.
Harding P; Carretero OA; Beierwaltes WH
J Hypertens; 2000 Aug; 18(8):1107-13. PubMed ID: 10954003
[TBL] [Abstract][Full Text] [Related]
18. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
Husková Z; Kramer HJ; Thumová M; Vanourková Z; Bürgelová M; Teplan V; Malý J; Cervenka L
Kidney Blood Press Res; 2006; 29(2):74-83. PubMed ID: 16651849
[TBL] [Abstract][Full Text] [Related]
19. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
Vernerová Z; Kramer HJ; Bäcker A; Cervenka L; Opocenský M; Husková Z; Vanourková Z; Eis V; Chábová VC; Tesar V; Malý J; Vanecková I
Vascul Pharmacol; 2008; 48(4-6):165-73. PubMed ID: 18372220
[TBL] [Abstract][Full Text] [Related]
20. Ovariectomy enhances renal cortical expression and function of cyclooxygenase-2.
Tada Y; Ichihara A; Koura Y; Okada H; Kaneshiro Y; Hayashi M; Saruta T
Kidney Int; 2004 Nov; 66(5):1966-76. PubMed ID: 15496168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
